Mutation spectrum of the GATA4 gene in patients with idiopathic atrial fibrillation

Molecular Biology Reports

Volumn 39, Issue 8, 2012, Pages 8127-8135

  Wang, Jun ^a   Sun, Yu Min ^a   Yang, Yi Qing ^b  

^a Shanghai Jing An District Hospital   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Atrial fibrillation; GATA4; Molecular genetics; Mutation; Transcription factor

Indexed keywords

GENOMIC DNA; TRANSCRIPTION FACTOR GATA 4;

ADULT; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; EXON; FEMALE; GATA 4 GENE; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC CONSERVATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HEART ATRIUM FIBRILLATION; HETEROZYGOTE; HUMAN; IDIOPATHIC DISEASE; INTRON; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; MOLECULAR DYNAMICS; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PEDIGREE ANALYSIS; PHENOTYPE; PREVALENCE; SEQUENCE ALIGNMENT; WILD TYPE; ANIMAL; ASIAN; CELL LINE; CERCOPITHECUS; CHINA; GENETIC PREDISPOSITION; GENETIC TRANSCRIPTION; GENETICS; MIDDLE AGED; MOLECULAR GENETICS; MUTATION; PEDIGREE;

ADULT; AMINO ACID SEQUENCE; ANIMALS; ASIAN CONTINENTAL ANCESTRY GROUP; ATRIAL FIBRILLATION; BASE SEQUENCE; CELL LINE; CERCOPITHECUS AETHIOPS; CHINA; FEMALE; GATA4 TRANSCRIPTION FACTOR; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; PEDIGREE; SEQUENCE ALIGNMENT; TRANSCRIPTION, GENETIC; YOUNG ADULT;

EID: 84868654770     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-1660-6     Document Type: Article

References (48)

1. European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery; Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH; ESC Committee for Practice Guidelines, Vahanian A, Auricchio A, Bax J, Ceconi C, Dean V, Filippatos G, Funck-Brentano C, Hobbs R, Kearney P, McDonagh T, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Vardas PE, Widimsky P; Document Reviewers, Vardas PE, Agladze V, Aliot E, Balabanski T, Blomstrom-Lundqvist C, Capucci A, Crijns H, Dahlöf B, Folliguet T, Glikson M, Goethals M, Gulba DC, Ho SY, Klautz RJ, Kose S, McMurray J, Perrone Filardi P, Raatikainen P, Salvador MJ, Schalij MJ, Shpektor A, Sousa J, Stepinska J, Uuetoa H, Zamorano JL, Zupan I (2010) Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace 12:1360-1420
2. Stefansdottir H, Aspelund T, Gudnason V, Arnar DO (2011) Trends in the incidence and prevalence of atrial fibrillation in Iceland and future projections. Europace 13:1110-1117
3. Lloyd-Jones DM, Wang TJ, Leip EP, Larson MG, Levy D, Vasan RS, D'Agostino RB, Massaro JM, Beiser A, Wolf PA, Benjamin EJ (2004) Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation 110:1042-1046
4. Wolf PA, Abbott RD, Kannel WB (1991) Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 22:983-988
5. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D (1998) Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 98:946-952
6. Roy D, Talajic M, Dubuc M, Thibault B, Guerra P, Macle L, Khairy P (2009) Atrial fibrillation and congestive heart failure. Curr Opin Cardiol 24:29-34
7. Knecht S, Oelschlager C, Duning T, Lohmann H, Albers J, Stehling C, Heindel W, Breithardt G, Berger K, Ringelstein EB, Kirchhof P, Wersching H (2008) Atrial fibrillation in stroke-free patients is associated with memory impairment and hippocampal atrophy. Eur Heart J 29:2125-2132
8. Guédon-Moreau L, Capucci A, Denjoy I, Morgan CC, Périer A, Leplège A, Kacet S (2010) Impact of the control of symptomatic paroxysmal atrial fibrillation on health-related quality of life. Europace 12:634-642
9. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Kay GN, Le Huezey JY, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann LS, Smith SC Jr, Priori SG, Estes NA 3rd, Ezekowitz MD, Jackman WM, January CT, Lowe JE, Page RL, Slotwiner DJ, Stevenson WG, Tracy CM, Jacobs AK, Anderson JL, Albert N, Buller CE, Creager MA, Ettinger SM, Guyton RA, Halperin JL, Hochman JS, Kushner FG, Ohman EM, Stevenson WG, Tarkington LG, Yancy CW, American College of Cardiology Foundation/American Heart Association Task Force, (2011) 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American college of cardiology foundation/American heart association task force on practice guidelines. Circulation 123:e269-e367
10. Ellinor PT, Yoerger DM, Ruskin JN, MacRae CA (2005) Familial aggregation in lone atrial fibrillation. Hum Genet 118:179-184
11. Arnar DO, Thorvaldsson S, Manolio TA, Thorgeirsson G, Kristjansson K, Hakonarson H, Stefansson K (2006) Familial aggregation of atrial fibrillation in Iceland. Eur Heart J 27:708-712
12. Junttila MJ, Raatikainen MJ, Perkiömäki JS, Hong K, Brugada R, Huikuri HV (2007) Familial clustering of lone atrial fibrillation in patients with saddleback-type ST-segment elevation in right precordial leads. Eur Heart J 28:463-468
13. Christophersen IE, Ravn LS, Budtz-Joergensen E, Skytthe A, Haunsoe S, Svendsen JH, Christensen K (2009) Familial aggregation of atrial fibrillation: a study in Danish twins. Circ Arrhythm Electrophysiol 2:378-383
14. Yang YQ, Zhang XL, Wang XH, Tan HW, Shi HF, Fang WY, Liu X (2010) Familial aggregation of lone atrial fibrillation in the Chinese population. Intern Med 49:2385-2391
15. Fox CS, Parise H, D'Agostino RB Sr, Lloyd-Jones DM, Vasan RS, Wang TJ, Levy D, Wolf PA, Benjamin EJ (2004) Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. J Am Med Assoc 291:2851-2855
16. Lubitz SA, Yin X, Fontes JD, Magnani JW, Rienstra M, Pai M, Villalon ML, Vasan RS, Pencina MJ, Levy D, Larson MG, Ellinor PT, Benjamin EJ (2010) Association between familial atrial fibrillation and risk of new-onset atrial fibrillation. J Am Med Assoc 304:2263-2269
17. Lubitz SA, Yi BA, Ellinor PT (2010) Genetics of atrial fibrillation. Heart Fail Clin 6:239-247
18. Darbar D, Herron KJ, Ballew JD, Jahangir A, Gersh BJ, Shen WK, Hammill SC, Packer DL, Olson TM (2003) Familial atrial fibrillation is a genetically heterogeneous disorder. J Am Coll Cardiol 41:2185-2192
19. Nemer M (2008) Genetic insights into normal and abnormal heart development. Cardiovasc Pathol 17:48-54
20. Bruneau BG (2008) The developmental genetics of congenital heart disease. Nature 451:943-948
21. White RA, Dowler LL, Pasztor LM, Gatson LL, Adkison LR, Angeloni SV, Wilson DB (1995) Assignment of the transcription factor GATA4 gene to human chromosome 8 and mouse chromosome 14: Gata4 is a candidate gene for Ds (disorganization). Genomics 27:20-26
22. Maitra M, Schluterman MK, Nichols HA, Richardson JA, Lo CW, Srivastava D, Garg V (2009) Interaction of Gata4 and Gata6 with Tbx5 is critical for normal cardiac development. Dev Biol 326:368-377
23. Pu WT, Ishiwata T, Juraszek AL, Ma Q, Izumo S (2004) GATA4 is a dosage-sensitive regulator of cardiac morphogenesis. Dev Biol 275:235-244
24. Watt AJ, Battle MA, Li J, Duncan SA (2004) GATA4 is essential for formation of the proepicardium and regulates cardiogenesis. Proc Natl Acad Sci USA 101:12573-12578
25. Garg V, Kathiriya IS, Barnes R, Schluterman MK, King IN, Butler CA, Rothrock CR, Eapen RS, Hirayama-Yamada K, Joo K, Matsuoka R, Cohen JC, Srivastava D (2003) GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature 424:443-447
26. Nemer G, Fadlalah F, Usta J, Nemer M, Dbaibo G, Obeid M, Bitar F (2006) A novel mutation in the GATA4 gene in patients with Tetralogy of Fallot. Hum Mutat 27:293-294
27. Rajagopal SK, Ma Q, Obler D, Shen J, Manichaikul A, Tomita-Mitchell A, Boardman K, Briggs C, Garg V, Srivastava D, Goldmuntz E, Broman KW, Benson DW, Smoot LB, Pu WT (2007) Spectrum of heart disease associated with murine and human GATA4 mutation. J Mol Cell Cardiol 43:677-685
28. Posch MG, Boldt LH, Polotzki M, Richter S, Rolf S, Perrot A, Dietz R, Ozcelik C, Haverkamp W (2010) Mutations in the cardiac transcription factor GATA4 in patients with lone atrial fibrillation. Eur J Med Genet 53:201-203
29. Yang YQ, Wang MY, Zhang XL, Tan HW, Shi HF, Jiang WF, Wang XH, Fang WY, Liu X (2011) GATA4 loss-of-function mutations in familial atrial fibrillation. Clin Chim Acta 412:1825-1830
30. Jiang JQ, Shen FF, Fang WY, Liu X, Yang YQ (2011) Novel GATA4 mutations in lone atrial fibrillation. Int J Mol Med 28:1025-1032
31. Juang JM, Chern YR, Tsai CT, Chiang FT, Lin JL, Hwang JJ, Hsu KL, Tseng CD, Tseng YZ, Lai LP (2007) The association of human connexin 40 genetic polymorphisms with atrial fibrillation. Int J Cardiol 116:107-112
32. Brewer A, Pizzey J (2006) GATA factors in vertebrate heart development and disease. Expert Rev Mol Med 8:1-20
33. Posch MG, Perrot A, Berger F, Ozcelik C (2010) Molecular genetics of congenital atrial septal defects. Clin Res Cardiol 99:137-147
34. Shiojima I, Komuro I, Oka T, Hiroi Y, Mizuno T, Takimoto E, Monzen K, Aikawa R, Akazawa H, Yamazaki T, Kudoh S, Yazaki Y (1999) Context-dependent transcriptional cooperation mediated by cardiac transcription factors Csx/Nkx2.5 and GATA-4. J Biol Chem 274:8231-8239
35. Mommersteeg MT, Brown NA, Prall OW, de Gier-de Vries C, Harvey RP, Moorman AF, Christoffels VM (2007) Pitx2c and Nkx2-5 are required for the formation and identity of the pulmonary myocardium. Circ Res 101:902-909
36. Zhu W, Shiojima I, Hiroi Y, Zou Y, Akazawa H, Mizukami M, Toko H, Yazaki Y, Nagai R, Komuro I (2000) Functional analyses of three Csx/Nkx-2.5 mutations that cause human congenital heart disease. J Biol Chem 275:35291-35296
37. Haïssaguerre M, Jaïs P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Métayer P, Clémenty J (1998) Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 339:659-666
38. Nattel S (2003) Basic electrophysiology of the pulmonary veins and their role in atrial fibrillation: precipitators, perpetuators, and perplexers. J Cardiovasc Electrophysiol 14:1372-1375
39. Mommersteeg MT, Hoogaars WM, Prall OW, de Gier-de Vries C, Wiese C, Clout DE, Papaioannou VE, Brown NA, Harvey RP, Moorman AF, Christoffels VM (2007) Molecular pathway for the localized formation of the sinoatrial node. Circ Res 100:354-362
40. Gutierrez-Roelens I, De Roy L, Ovaert C, Sluysmans T, Devriendt K, Brunner HG, Vikkula M (2006) A novel CSX/NKX2-5 mutation causes autosomal-dominant AV block: are atrial fibrillation and syncopes part of the phenotype? Eur J Hum Genet 14:1313-1316
41. Watanabe Y, Benson DW, Yano S, Akagi T, Yoshino M, Murray JC (2002) Two novel frameshift mutations in NKX2.5 result in novel features including visceral inversus and sinus venosus type ASD. J Med Genet 39:807-811
42. Pabst S, Wollnik B, Rohmann E, Hintz Y, Glänzer K, Vetter H, Nickenig G, Grohé C (2008) A novel stop mutation truncating critical regions of the cardiac transcription factor NKX2-5 in a large family with autosomal-dominant inherited congenital heart disease. Clin Res Cardiol 97:39-42
43. Hodgson-Zingman DM, Karst ML, Zingman LV, Heublein DM, Darbar D, Herron KJ, Ballew JD, de Andrade M, Burnett JC Jr, Olson TM (2008) Atrial natriuretic peptide frameshift mutation in familial atrial fibrillation. N Engl J Med 359:158-165
44. Gollob MH, Jones DL, Krahn AD, Danis L, Gong XQ, Shao Q, Liu X, Veinot JP, Tang AS, Stewart AF, Tesson F, Klein GJ, Yee R, Skanes AC, Guiraudon GM, Ebihara L, Bai D (2006) Somatic mutations in the connexin 40 gene (GJA5) in atrial fibrillation. N Engl J Med 354:2677-2688
45. Yang YQ, Liu X, Zhang XL, Wang XH, Tan HW, Shi HF, Jiang WF, Fang WY (2010) Novel connexin40 missense mutations in patients with familial atrial fibrillation. Europace 12:1421-1427
46. Yang YQ, Zhang XL, Wang XH, Tan HW, Shi HF, Jiang WF, Fang WY, Liu X (2010) Connexin40 nonsense mutation in familial atrial fibrillation. Int J Mol Med 26:605-610
47. Firouzi M, Ramanna H, Kok B, Jongsma HJ, Koeleman BP, Doevendans PA, Groenewegen WA, Hauer RN (2004) Association of human connexin40 gene polymorphisms with atrial vulnerability as a risk factor for idiopathic atrial fibrillation. Circ Res 95:e29-e33
48. Wirka RC, Gore S, Van Wagoner DR, Arking DE, Lubitz SA, Lunetta KL, Benjamin EJ, Alonso A, Ellinor PT, Barnard J, Chung MK, Smith JD (2011) A common connexin-40 gene promoter variant affects connexin-40 expression in human atria and is associated with atrial fibrillation. Circ Arrhythm Electrophysiol 4:87-93